Skip to content

Clinical trials

Completed Adenocarcinoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: Germany Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20083
20093
20102
20113
20131
20143
20152
20163
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AIO-Studien-gGmbH3
PD Dr Markus Möhler2
Ariad Pharmaceuticals1
Australasian Gastro-Intestinal Trials Group1
Boehringer Ingelheim1
Carmen Schade-Brittinger1
Celgene1
Clovis Oncology, Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma28
Carcinoma6
Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Digestive System Diseases4
Digestive System Neoplasms4
Neoplasms by Site4
Carcinoma, Renal Cell3
Carcinoma, Squamous Cell3
Endocrine Gland Neoplasms3

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.